Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Embella for superficial lipoma
IRCT20240416061507N2Phase 4Completed
- Sponsor
- Espad Pharmed
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium deoxycholate in lipoma, sponsored by Espad Pharmed. Primary endpoints: Percentage of lipoma size reduction, Number of injection sessions and 2 more. Started Aug 2024; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
lipoma
Beyond the preview
Go deeper on IRCT20240416061507N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240416061507N2.